Khalid Ibrahim, D., & Akram Yahya, N. (2023). Effects of Epigallocatechin-3-Gallate (EGCG) in Diabetes Mellitus as a DYRK1A inhibitor. Iraqi Journal of Pharmacy, 20(2), 168–173. https://doi.org/10.33899/iphr.2023.141712.1048